Perspective Therapeutics Inc [CATX] stock prices are up 0.57% to $3.53 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CATX shares have gain 10.66% over the last week, with a monthly amount drifted -4.85%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Perspective Therapeutics Inc [AMEX: CATX] stock has seen the most recent analyst activity on November 25, 2024, when BofA Securities downgraded its rating to a Neutral and also revised its price target to $5 from $24. Previously, UBS started tracking the stock with Buy rating on October 24, 2024, and set its price target to $20. On October 01, 2024, Wedbush initiated with a Outperform rating and assigned a price target of $25 on the stock. Truist started tracking the stock assigning a Buy rating and suggested a price target of $21 on September 25, 2024. BofA Securities initiated its recommendation with a Buy and recommended $24 as its price target on July 25, 2024.
The stock price of Perspective Therapeutics Inc [CATX] has been fluctuating between $2.70 and $19.05 over the past year. Currently, Wall Street analysts expect the stock to reach $21.75 within the next 12 months. Perspective Therapeutics Inc [AMEX: CATX] shares were valued at $3.53 at the most recent close of the market. An investor can expect a potential return of 516.15% based on the average CATX price forecast.
Analyzing the CATX fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -159.37%, Pretax Profit Margin comes in at -139.74%, and Net Profit Margin reading is -189.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.26 and Total Capital is -0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.30 points at the first support level, and at 3.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.69, and for the 2nd resistance point, it is at 3.85.
Ratios To Look Out For
It’s worth pointing out that Perspective Therapeutics Inc [AMEX:CATX]’s Current Ratio is 9.60. As well, the Quick Ratio is 9.60, while the Cash Ratio is 8.05.
Transactions by insiders
Recent insider trading involved HENSON HEIDI, Director, that happened on Dec 04 ’24 when 25975.0 shares were purchased. CEO, Spoor Johan M. completed a deal on Dec 04 ’24 to buy 8000.0 shares. Meanwhile, Director Williamson Robert F III bought 6266.0 shares on Nov 25 ’24.
